EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Inhibitory Role for Human CD96 Endodomain in T Cell Anti-Tumor Responses

Chelsia Qiuxia Wang iD, Fong Chan Choy, Arleen Sanny, Takashi Murakami, Andy Hee-Meng Tan iD, Kong-Peng Lam

Cells · 2023

DOI: 10.3390/cells12020309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Chelsia Qiuxia Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Bioprocessing Technology Institute, Agency for Science, Technology and Research, 20 Biopolis Way, #06-01 Centros, Singapore 138668, Singapore. Hauptthemen laut MEDLINE: Neoplasms, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agency for Science, Technology and Research, Singapore (A*STAR), Bioprocessing Technology Institute, AMED.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint blockade (ICB) therapy involves the inhibition of immune checkpoint regulators which reverses their limitation of T cell anti-tumor responses and results in long-lasting tumor regression. However, poor clinical response or tumor relapse was observed in some patients receiving such therapy administered via antibodies blocking the cytotoxic T lymphocyte-associated protein 4 (CTLA-4) or the programmed cell death 1 (PD-1) pathway alone or in combination, suggesting the involvement of additional immune checkpoints. CD96, a possible immune checkpoint, was previously shown to suppress natural killer (NK) cell anti-tumor activity but its role in human T cells remains controversial. Here, we demonstrate that CRISPR/Cas9-based deletion of CD96 in human T cells enhanced their killing of leukemia cells in vitro. T cells engineered with a chimeric antigen receptor (CAR) comprising human epidermal growth factor receptor 2 (EGFR2/HER2)-binding extracellular region and intracellular regions of CD96 and CD3ζ (4D5-96z CAR-T cells) were less effective in suppressing the growth of HER2-expressing tumor cells in vitro and in vivo compared with counterparts bearing CAR that lacked CD96 endodomain (4D5-z CAR-T cells). Together, our findings implicate a role for CD96 endodomain in attenuating T cell cytotoxicity and support combination tumor immunotherapy targeting multiple rather than single immune checkpoints.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsReceptors, Chimeric AntigenHumansT-LymphocytesKiller Cells, NaturalImmunotherapyAntigens, CD

Stichwörter der Autor:innen

CD96T cell cytotoxicityimmune checkpointimmunologic receptorsimmunotherapy

Substanzen

Receptors, Chimeric AntigenAntigens, CD

Autor:innen und Institutionen

  • Bioprocessing Technology Institute, Agency for Science, Technology and Research, 20 Biopolis Way, #06-01 Centros, Singapore 138668, Singapore.
  • Department of Microbiology, Saitama Medical University, Moroyama, Saitama 350-0495, Japan.
  • Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.
  • Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
  • Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
  • Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.

ORCID-Profile: Chelsia Qiuxia Wang, Andy Hee-Meng Tan

Förderung

  • Agency for Science, Technology and Research, Singapore (A*STAR)
  • Bioprocessing Technology Institute
  • AMED

Zitieren

APA

Wang, C. Q., Choy, F. C., Sanny, A., Murakami, T., Tan, A. H., & Lam, K. P. (2023). An Inhibitory Role for Human CD96 Endodomain in T Cell Anti-Tumor Responses. Cells. https://doi.org/10.3390/cells12020309

Vancouver

Wang CQ, Choy FC, Sanny A, Murakami T, Tan AH, Lam KP. An Inhibitory Role for Human CD96 Endodomain in T Cell Anti-Tumor Responses. Cells. 2023. doi:10.3390/cells12020309

BibTeX
@article{Wang2023,
  author = {Wang, Chelsia Qiuxia and Choy, Fong Chan and Sanny, Arleen and Murakami, Takashi and Tan, Andy Hee-Meng and Lam, Kong-Peng},
  title = {An Inhibitory Role for Human CD96 Endodomain in T Cell Anti-Tumor Responses},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12020309}
}
Kostenlos starten →